Maternal health and pregnancy outcomes in autosomal dominant tubulointerstitial kidney disease

Obstet Med. 2023 Sep;16(3):162-169. doi: 10.1177/1753495X221133150. Epub 2022 Oct 19.

Abstract

Introduction: Autosomal dominant tubulointerstitial kidney disease (ADTKD) is an increasingly recognized cause of chronic kidney disease. ADTKD pregnancy outcomes have not previously been described.

Methods: A cross-sectional survey was sent to women from ADTKD families.

Results: Information was obtained from 85 afffected women (164 term pregnancies) and 23 controls (50 pregnancies). Only 16.5% of genetically affected women knew they had ADTKD during pregnancy. Eighteen percent of ADTKD mothers had hypertension during pregnancy versus 12% in controls (p = 0.54) and >40% in comparative studies of chronic kidney disease in pregnancy. Eleven percent of births of ADTKD mothers were <37 weeks versus 0 in controls (p < 0.0001). Cesarean section occurred in 19% of pregnancies in affected women versus 38% of unaffected individuals (p = 0.06). Only 12% of babies required a neonatal intensive care unit stay.

Conclusions: ADTKD pregnancies had lower rates of hypertension during pregnancy versus other forms of chronic kidney disease, which may have contributed to good maternal and fetal outcomes.

Keywords: MUC1; Maternal health; UMOD; autosomal dominant tubulointerstitial kidney disease; epidemiology; pregnancy.